Mergers & Acquisitions

  • February 26, 2026

    Brink's, NCR Ink $6.6B Deal As Sidley, King & Spalding Advise

    The Brink's Co. said Thursday it has agreed to purchase NCR Atleos in a cash-and-stock transaction valued at approximately $6.6 billion, with Sidley Austin LLP advising Brink's and King & Spalding LLP guiding NCR.

  • February 26, 2026

    House Bill Would Cap FCC License Reviews At 180 Days

    A bipartisan U.S. House bill introduced Thursday would codify the Federal Communications Commission's standard 180-day limit on reviewing license applications, potentially speeding up merger reviews.

  • February 26, 2026

    Chancery Asked To OK $7.6M Deal To End $1.5B De-SPAC Row

    Stockholders of special purpose acquisition company HighCape Capital LP have sought Delaware Court of Chancery approval for a $7.6 million settlement of a class suit accusing company principals of pursuing an overpriced take-public merger of biopharmaceutical tech company Quantum-Si, in litigation complicated by an unusual discovery stumble.

  • February 26, 2026

    DirecTV Urges Top FCC Officials To Nix Nexstar-Tegna Deal

    DirecTV went to the top ranks of the Federal Communications Commission in recent days to push against the proposed merger of TV station giants Nexstar and Tegna, calling it a clear threat to local media competition.

  • February 26, 2026

    Chancery Refuses For Now To Make Hecate Pay Lenders $75M

    The Delaware Chancery Court has denied renewable energy lenders' bid to immediately seize $75 million in disputed settlement proceeds, ruling that although the lenders are likely to succeed on parts of their contract claims, they failed to justify the extraordinary step of a mandatory injunction.

  • February 26, 2026

    Willkie Lands A&O Shearman Corporate Finance Pros In Calif.

    Willkie Farr & Gallagher LLP is boosting its transactional team, bringing in a pair of Allen Overy Shearman Sterling corporate finance aces as partners in its Silicon Valley office, one of whom will also become the new co-managing partner of that office.

  • February 26, 2026

    BlueScope Turns $11B Bid Down But Still Open To Talks

    Australia's BlueScope Steel Ltd. on Thursday said a revised roughly AU$15 billion ($11 billion) takeover proposal from SGH Ltd. and Steel Dynamics Inc. does not adequately reflect the company's valuation, but it remains open to further discussions.

  • February 26, 2026

    Barnes & Thornburg Lands Katten M&A Partner In NY

    Barnes & Thornburg LLP has expanded its mergers and acquisitions and private equity teams by hiring a former Katten Muchin Rosenman LLP partner.

  • February 26, 2026

    Freshfields Guides Asahi Kasei Unit In €780M Biopharma Deal

    Japanese conglomerate Asahi Kasei Corp. said Thursday it has agreed to buy biopharmaceutical company Aicuris for €780 million ($920 million) cash to fuel the German company's research and development efforts, in a deal steered by Freshfields LLP and Gibson Dunn & Crutcher LLP.

  • February 26, 2026

    A&O Shearman-Led UAE Aviation Biz To Buy $7B Leasing Co.

    Dubai Aerospace said Thursday that it has agreed to acquire international aircraft leasing company Macquarie AirFinance Ltd. for approximately $7 billion in a bid to become "one of the world's most preeminent aircraft leasing companies."

  • February 26, 2026

    Willkie Leads Victory Capital's Rival Bid For Janus Henderson

    U.S. investment manager Victory Capital said Thursday that it is making an offer for asset management group Janus Henderson, which is 16% higher than a bid tabled by Trian Fund Management.

  • February 25, 2026

    Dems Demand Explanation For DOJ Antitrust Chief's Exit

    Two Democrats on the House Judiciary Committee demanded Wednesday that U.S. Attorney General Pam Bondi explain to lawmakers why the U.S. Department of Justice's antitrust chief was forced to resign, expressing concern about the administration's potential interference with merger reviews and antitrust litigation.

  • February 25, 2026

    IP Co. Investors Sue Over AI-Focused Acquisition Losses

    Executives and directors of semiconductor technology company Synopsys Inc. were hit with a shareholder's derivative suit accusing them of misleading investors about the operational challenges faced by one of its segments following a $35 billion acquisition of an artificial intelligence company made in 2024.

  • February 25, 2026

    Winston & Strawn-Led SPAC Mozayyx Prices Upsized $261M IPO

    Special purpose acquisition company Mozayyx Acquisition Corp. began trading publicly on Wednesday after raising $261 million in its upsized initial public offering.

  • February 25, 2026

    Cox Tells Calif. It Needs Final Ruling On Charter By July

    Cable behemoth Cox Communications has told the California Public Utilities Commission that it needs a final decision by July on its $34.5 billion merger with Charter so that the companies have time to close the deal before their federal merger clearance period expires.

  • February 25, 2026

    EU, UK To Share Info On 'Significant' Antitrust Probes

    British and European Union officials signed a new agreement Wednesday promising to notify each other of major merger and antitrust probes and coordinate their efforts "when necessary," in what they called the first dedicated competition cooperation agreement following the United Kingdom's withdrawal from the EU.

  • February 25, 2026

    Engie To Buy UK Power Networks At $21.4B Enterprise Value

    French electric utility Engie said Wednesday it has agreed to acquire UK Power Networks, a top British electricity distribution operator, for an equity value of £10.5 billion ($14.2 billion) and an enterprise value of £15.8 billion, which is about $21.4 billion.

  • February 25, 2026

    Pension Fund Presses For CEO Texts In $60B Merger Fight

    A union pension fund stockholder urged the Delaware Supreme Court on Wednesday to revive its bid for access to a former Pioneer Natural Resources Co. CEO's undisclosed text messages and emails, arguing that the Delaware Chancery Court set an "impossible" standard in denying inspection of communications tied to the company's $60 billion sale to Exxon Mobil Corp.

  • February 25, 2026

    BasePoint's £543M Offer For Lender Sweetened With Dividend

    Lender International Personal Finance said Wednesday that it can pay a special dividend to its shareholders in order to boost a £543 million ($736 million) takeover offer from American specialist finance group BasePoint Capital.

  • February 25, 2026

    EQT Will Not Make Offer For Oxford Biomedica

    EQT said Wednesday that it does not plan to make an offer to buy Oxford Biomedica PLC after holding preliminary talks about potentially acquiring the U.K. business.

  • February 25, 2026

    2 Firms Help Novacap Land $3.8B For Tech-Focused Fund

    Private equity shop Novacap, advised by Willkie Farr & Gallagher LLP and Davies Ward Phillips & Vineberg LLP, on Wednesday revealed it had closed its seventh technology-centered fund with nearly $3.8 billion in committed capital.

  • February 25, 2026

    Taylor Wessing Steers £186M Bid For Fintech Fund

    European investor Verdane said Wednesday that it has offered to acquire Augmentum Fintech, a financial technology investment fund, in a cash deal worth about £185.7 million ($252 million).

  • February 25, 2026

    Novo's $2.1B Vivtex Deal Boosts Obesity Drug Pipeline

    Novo Nordisk said on Wednesday it is partnering with Vivtex Corp. on a deal worth up to $2.1 billion to develop drugs for obesity and related conditions, pressing ahead with a weight loss-drug franchise that has delivered rapid growth alongside regulatory scrutiny and courtroom clashes.

  • February 25, 2026

    Live Nation Judge Not 'Inclined' To Delay Trial For Appeal

    A Manhattan federal judge said Wednesday he is likely to deny counsel for Live Nation's request to appeal rulings sending the government's monopolization claims to trial, after antitrust regulators called that request a "desperate plea" for a delay.

  • February 25, 2026

    GlaxoSmithKline Buys Canadian Drugmaker For $950M

    GSK PLC said Wednesday that it has agreed to pay $950 million in cash for Canadian clinical-stage drugmaker 35Pharma Inc., which is developing a medicine to treat a type of high blood pressure known as pulmonary hypertension.

Expert Analysis

  • Series

    Playing Baseball Makes Me A Better Lawyer

    Author Photo

    Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.

  • Building Better Earnouts In The Current M&A Climate

    Author Photo

    In the face of market uncertainty, we've seen a continued reliance on earnouts in M&A deals so far this year, but to reduce the risk of related litigation, it's important to use objective standards, apply company metrics cautiously and ensure short time periods, among other best practices, say attorneys at White & Case.

  • Series

    Law School's Missed Lessons: Skillful Persuasion

    Author Photo

    In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.

  • A Look At Trump 2.0 Antitrust Enforcement So Far

    Author Photo

    The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.

  • Litigation Inspiration: How To Respond After A Loss

    Author Photo

    Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.

  • The Metamorphosis Of The Major Questions Doctrine

    Author Photo

    The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.

  • Biotech Collaborations Can Ease Uncertainty Amid FDA Shift

    Author Photo

    As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.

  • Series

    Playing Mah-Jongg Makes Me A Better Mediator

    Author Photo

    Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.

  • Business Court Bill Furthers Texas' Pro-Corporate Strategy

    Author Photo

    The Texas Legislature's recent bill to enhance corporate protections and expand access to the Texas Business Court by refining its jurisdictional standards is just the latest step in the state's playbook for becoming the new center of corporate America, say attorneys at Katten.

  • FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda

    Author Photo

    While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.

  • Series

    Law School's Missed Lessons: Navigating Client Trauma

    Author Photo

    Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.

  • Opinion

    4 Former Justices Would Likely Frown On Litigation Funding

    Author Photo

    As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.

  • Takeaways From EU's Review Of Merger Control Guidelines

    Author Photo

    The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.

  • How Attys Can Use AI To Surface Narratives In E-Discovery

    Author Photo

    E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.

  • Identifying Data Center Investment Challenges, Opportunities

    Author Photo

    The role of data centers is expanding, as are new opportunities for private capital investors, but there are issues to consider, including finance models and contract complexity, as well as power supply, cyber threat resilience and data sovereignty, say lawyers at Ropes & Gray.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.